Table 6.
CHARACTERISTICS | ARM A (45) | ARM B (38) | P-VALUE | ||
---|---|---|---|---|---|
NUMBER | % | NUMBER | % | ||
Age (At time of metastases) | |||||
18–<40 | 2 | 4 | 3 | 7 | 0.09 |
40–<51 | 9 | 20 | 10 | 26 | 0.08 |
51–<65 | 16 | 36 | 14 | 37 | 0.15 |
65–70 | 18 | 40 | 11 | 30 | 0.06 |
Age (median) | 53 | – | 50 | – | 0.9 |
Body mass index (BMI) | |||||
<25 | 0 | 0 | 22 | 58 | – |
25–29.9 | 0 | 0 | 16 | 42 | – |
≥30% | 45 | 100 | 0 | 0 | – |
BMI (median) | 33 | – | 21 | – | 0.04 |
Performance status (ECOG) | |||||
0 | 22 | 49 | 24 | 58 | 0.09 |
1 | 15 | 34 | 10 | 27 | 0.06 |
2 | 8 | 17 | 6 | 15 | 0.09 |
Performance status (median) | 0 | – | 0 | – | 0.1 |
Pathological classification | |||||
Ductal | 41 | 91 | 32 | 84 | 0.06 |
Lobular | 4 | 9 | 6 | 16 | 0.08 |
Pathological grade | |||||
1 | 0 | 0 | 0 | 0 | – |
2 | 19 | 42 | 18 | 47 | 0.09 |
3 | 26 | 58 | 20 | 53 | 0.07 |
Grade (median) | 3 | – | 3 | – | 0.1 |
Initial stage (pathological) | |||||
I–II | 15 | 33 | 10 | 27 | 0.06 |
III | 14 | 31 | 13 | 34 | 0.09 |
IV | 16 | 36 | 15 | 39 | 0.08 |
Number of positive lymph node | |||||
0 | 2 | 4 | 2 | 5 | 0.1 |
1–3 | 13 | 29 | 8 | 21 | 0.07 |
4–9 | 14 | 31 | 10 | 26 | 0.08 |
>9 | 3 | 7 | 4 | 11 | 0.06 |
Unknown | 13 | 29 | 14 | 37 | 0.06 |
Lymph node number (median) | 5 | – | 4.5 | 0.1 | |
Metastases site | |||||
Lung | 15 | 33 | 12 | 32 | 0.09 |
Liver | 20 | 45 | 16 | 42 | 0.07 |
Both | 5 | 11 | 3 | 8 | 0.08 |
Bone | 1 | 2 | 2 | 5 | 0.06 |
Bone and visceral | 4 | 9 | 5 | 13 | 0.06 |
Receptor status: Her 2 neu | |||||
Positive | 16 | 35 | 13 | 34 | 0.1 |
Negative | 29 | 65 | 25 | 66 | 0.1 |
Invasion | |||||
Lymphatic | 14 | 31 | 18 | 47 | 0.06 |
Vascular/Perineural | 10 | 22 | 12 | 31 | 0.06 |